| Detailed information |
|---|
| CancerLivER ID | 2131 |
| Biomarker | SAP |
| Biomarker Name/Symbol (given in Publication) | SAP |
| Biomolecule | Protein |
| Subject | Human |
| Degree of Validity | Biomarkers for HCC development in HCV-infected cirrhotic patients and validated on independent dataset |
| Experimental Condition | Normal vs HCV-infected HCC patients, Normals vs non HCV-infected HCC |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Downregulated in HCV-infected HCC patients |
| Level of significance | p < 0.01 |
| Source | Plasma |
| PMID | 23944848 |
| Type of Biomarker | Diagnostic |
| Pathway | Lectin -pathway |
| Cohort | Training cohort : 4 HCV-infected HCC patients (tumour group) and 3 HCV-infected non-HCC individuals (control group); Validation cohort contain 25 controls and 35 HCC patients. |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | Human HCV-HCC, HCC |
| Year of Publication | 2014 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |